Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics
yahoo.com
news
2022-10-18 19:25:00

- Yapan can now support end-to-end development and manufacturing of RNA, DNA and gene therapy products starting from plasmids



- Expansion inaugurated by Telangana Minister Kalvakuntla Taraka Rama Rao and Piramal Pharma Executives



- New facility is part of an $8M USD expansion plan; represents first major expansion since the initial investment from Piramal in December 2021

MUMBAI, India, Oct. 18, 2022 /PRNewswire/ -- Piramal Pharma Limited (PPL) today announced that Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India.
